Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional

Bibliographic Details
Main Author: Akihisa Imagawa
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Journal of Diabetes Investigation
Online Access:https://doi.org/10.1111/jdi.13450
_version_ 1819087823326674944
author Akihisa Imagawa
author_facet Akihisa Imagawa
author_sort Akihisa Imagawa
collection DOAJ
first_indexed 2024-12-21T21:42:16Z
format Article
id doaj.art-de36459c9bdc4b7984528db35f42477c
institution Directory Open Access Journal
issn 2040-1116
2040-1124
language English
last_indexed 2024-12-21T21:42:16Z
publishDate 2021-06-01
publisher Wiley
record_format Article
series Journal of Diabetes Investigation
spelling doaj.art-de36459c9bdc4b7984528db35f42477c2022-12-21T18:49:20ZengWileyJournal of Diabetes Investigation2040-11162040-11242021-06-0112691791910.1111/jdi.13450Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventionalAkihisa Imagawa0Department of Internal Medicine (I) Osaka Medical College Takatsuki Japanhttps://doi.org/10.1111/jdi.13450
spellingShingle Akihisa Imagawa
Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
Journal of Diabetes Investigation
title Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
title_full Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
title_fullStr Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
title_full_unstemmed Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
title_short Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
title_sort two types of fulminant type 1 diabetes mellitus immune checkpoint inhibitor related and conventional
url https://doi.org/10.1111/jdi.13450
work_keys_str_mv AT akihisaimagawa twotypesoffulminanttype1diabetesmellitusimmunecheckpointinhibitorrelatedandconventional